Levosulpiride Tablet Suppliers & Bulk Manufacturers
Available Forms: Oral tablets, capsules
Available Strengths: 25 mg, 50 mg, 75 mg, 100 mg
Reference Brands: Levoset (India), Levopride (India/LATAM)
Category:
Antipsychotropic Drugs
Levosulpiride, used for GERD, dyspepsia, and psychiatric disorders, is available in oral and injectable forms. Though not FDA-approved in the US, it is sold in select EU regions under brands like Levopraid. B2B platforms offer bulk Levosulpiride from GMP-certified suppliers for international pharmaceutical distribution.
Levosulpiride Tablet is available in Oral tablets, capsules
and strengths such as 25 mg, 50 mg, 75 mg, 100 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Levosulpiride Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Levosulpiride Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Levosulpiride is a substituted benzamide antipsychotic and prokinetic agent used for dyspepsia, GERD, and psychiatric conditions such as depression and schizophrenia. Available in oral (25 mg, 50 mg, 75 mg) and injectable (25 mg/2 ml, 50 mg/2 ml) forms, Levosulpiride is marketed in select EU regions under brands like Levopraid and Neoprad. While not FDA-approved in the US, it is in demand across Asia, Eastern Europe, and Latin America. Pharma B2B buyers source Levosulpiride for therapeutic areas including GI motility and mood disorders. GMP-compliant manufacturers offer bulk supply solutions for hospitals, clinics, and global distributors.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing